SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma

NCT07104331 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Epithelioid Hemangioendothelioma (EHE)

Interventions

DRUG: nab-Sirolimus

Sponsor

Sarcoma Alliance for Research through Collaboration